BILLIE WALTERS: Open Payments
NPI 1477938090 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,778 in 278 payments from 25 companies in 2025. Trend: 2023 $4,340 · 2024 $7,541 · 2025 $6,778
Food & beverage: $5,551Travel & lodging: $1,166Education: $61
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 9 | $1,724 |
| ABBVIE INC. | 75 | $959 |
| Novartis Pharmaceuticals Corporation | 26 | $432 |
| PFIZER INC. | 40 | $431 |
| UCB, Inc. | 17 | $417 |
| Amgen Inc. | 8 | $391 |
| Biogen, Inc. | 14 | $332 |
| Alexion Pharmaceuticals, Inc. | 9 | $329 |
| Teva Pharmaceuticals USA, Inc. | 11 | $239 |
| Janssen Biotech, Inc. | 7 | $202 |
Products named: VNS Therapy, BOTOX, KESIMPTA, ULTOMIRIS, NURTEC ODT, QULIPTA, UPLIZNA, AUSTEDO XR.
Industry payments across KY — which companies pay providers there.
